Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1390986

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1390986

Antimicrobial Susceptibility Testing Global Market Report 2024

Published: Pre-Order
PAGES: 200 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 5000
PDF (Site License)
USD 7500
PDF (Enterprise License)
USD 10000

Add to Cart

“Antimicrobial Susceptibility Testing Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antimicrobial susceptibility testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antimicrobial susceptibility testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The antimicrobial susceptibility testing market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Antibacterial Testing; Antifungal Testing; Antiparasitic Testing; Other Types
  • 2) By Products: Manual Antimicrobial Susceptibility Testing Products; Automated Laboratory Instruments; Consumables
  • 3) By Application: Diagnostics; Drug Discovery and Development; Epidemiology; Other Applications
  • 4) By End User: Hospitals And Diagnostic Centers; Pharmaceutical And Biotechnology Companies; Research And Academic Institutes; Clinical Research Organizations (CROs)
  • Companies Mentioned: BioMerieux SA; Becton Dickinson and Company; Thermo Fisher Scientific Inc.; Danaher Corporation; Bio-Rad Laboratories Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Antimicrobial susceptibility testing (AST) is a laboratory procedure conducted by clinical professionals to determine the most effective antimicrobial specimen for individual patients. The market for antimicrobial susceptibility testing involves the sales of such testing services provided by entities, including organizations, sole traders, and partnerships, engaged in laboratory services.

The primary types of AST procedures include antibacterial testing, antifungal testing, antiparasitic testing, and others. Antifungal susceptibility testing assesses the ability of a specific organism to grow in vitro in the presence of a particular drug. AST products utilized in testing encompass manual antimicrobial susceptibility testing products, automated laboratory instruments, and other consumables. These products find applications in diagnostics, drug discovery and development, and epidemiology. Antimicrobial susceptibility testing is employed by hospitals, diagnostic centers, pharmaceutical and biotechnology companies, research and academic institutes, as well as clinical research organizations (CROs).

The antimicrobial susceptibility testing market research report is one of a series of new reports from The Business Research Company that provides antimicrobial susceptibility testing market statistics, including antimicrobial susceptibility testing industry global market size, regional shares, competitors with an antimicrobial susceptibility testing market share, detailed antimicrobial susceptibility testing market segments, market trends and opportunities, and any further data you may need to thrive in the antimicrobial susceptibility testing industry. This antimicrobial susceptibility testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antimicrobial susceptibility testing market size has grown strongly in recent years. It will grow from $4.03 billion in 2023 to $4.33 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The increase in the historic period can be attributed to factors such as the rise in healthcare expenditure, a growing aging population, increased awareness and education, regulatory support, and economic growth.

The antimicrobial susceptibility testing market size is expected to see strong growth in the next few years. It will grow to $5.46 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%. The anticipated growth in the forecast period can be attributed to the increasing prevalence of drug-resistant infections, a rise in healthcare infrastructure, a growing emphasis on drug discovery, and an increase in disposable income. Key trends expected in this period involve the adoption of automation and robotics, the integration of AI and machine learning, multiplexing techniques, the incorporation of telemedicine, and the development of rapid antimicrobial susceptibility testing (AST) methods.

The expansion of the antimicrobial susceptibility testing market is significantly influenced by the increasing incidence of infectious diseases worldwide. Infectious diseases, stemming from various microorganisms like bacteria, viruses, fungi, and parasites, have become more prevalent. Bacterial pneumonia, tuberculosis, and viral infections like smallpox and HIV/AIDS have seen high rates of infection and mortality. According to the World Health Organization (WHO) statistics from 2021, millions of individuals were affected by tuberculosis and HIV, leading to a substantial number of deaths. This surge in infectious cases has driven the necessity for susceptibility testing of these organisms to develop more effective drugs, consequently propelling the antimicrobial susceptibility testing market.

The mounting prevalence of chronic diseases is expected to be a significant factor fueling the growth of the antimicrobial susceptibility testing market. Chronic illnesses, which are enduring and often incurable conditions necessitating ongoing medical management, render individuals more vulnerable to various infections. Antimicrobial susceptibility testing plays a crucial role in identifying the specific pathogens responsible for these infections and determining the most effective antibiotics against them. For example, a report by the Centers for Disease Control and Prevention (CDC) in July 2022 highlighted that a considerable proportion of the American population grapples with chronic diseases, thereby increasing susceptibility to infections such as chronic lung diseases, heart disease, stroke, and diabetes. This rise in chronic conditions is a driving force behind the market's growth.

A notable trend emerging in the antimicrobial susceptibility testing market is the adoption of rapid testing methods aimed at preventing antibiotic misuse and ensuring more effective treatments. Various techniques, such as Fluorescence in situ hybridization (FISH) and QuickFish technology (OpGen), utilize probes targeting RNA to rapidly identify and test microbial susceptibility. For instance, the antimicrobial susceptibility testing system developed by Genefluidics Inc uses an electrochemical biosensor to measure bacterial growth by quantifying 16s rRNA molecules, ensuring swift and accurate testing. This emphasis on rapid testing methods stands as a key trend in the evolution of the antimicrobial susceptibility testing market, catering to the pressing need for timely and accurate analysis to guide effective treatment strategies.

Major companies in the antimicrobial susceptibility testing market are advancing through the development of innovative products like the First Point-of-Care (POC) Testing System. This groundbreaking system is designed to identify the presence or absence of bacteria and evaluate the efficacy of antimicrobials by utilizing urine samples from patients suspected of having urinary tract infections (UTIs). The introduction of this system marks a significant stride in the realm of antimicrobial susceptibility testing (AST) technologies. Its primary advantage lies in expediting the commencement of targeted antimicrobial therapy for patients diagnosed with infections. For example, in June 2023, Sysmex Corporation, a Japan-based company specializing in manufacturing reagents and equipment for clinical tests, introduced a rapid antimicrobial susceptibility testing system. This innovative system employs a unique and proprietary microfluidic technology, delivering AST results in as little as 30 minutes from the initiation of the measurement process. This is a substantial reduction compared to the several days typically required for conventional AST methods. The system's swift and accurate results revolutionize the efficiency and timeliness of treatment initiation, catering to the urgent needs of patients requiring targeted antimicrobial therapy.

Major companies operating in the antimicrobial susceptibility testing market include BioMerieux SA, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Danaher Corporation, Bio-Rad Laboratories Inc., Accelerate Diagnostics Inc., Hi-Media Laboratories, Creative Diagnostics, Merck KGaA, Roche Diagnostics Limited, Alifax Holding S.p.A., Synbiosis Ltd., Zhuhai DL Biotech Co. Ltd., Mast Group Ltd., ELITechGroup, Genefluidics Inc., Condalab, QuantaMatrix Inc., Bruker Corporation, Eurofins Scientific SE, Liofilchem s.r.l., Hardy Diagnostics, Micromax Technologies, Bioanalyse GmbH, Lab M Limited, Microbiologics Inc., Quidel Corporation, R-Biopharm AG, SSI Diagnostica A/S, VWR International LLC, ZeptoMetrix Corporation

North America was the largest region in the antimicrobial susceptibility testing market in 2023. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the antimicrobial susceptibility testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the antimicrobial susceptibility testing market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The antimicrobial susceptibility testing (AST) market includes revenues earned by dilution susceptibility tests and disc diffusion susceptibility tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r9346

Table of Contents

1. Executive Summary

2. Antimicrobial Susceptibility Testing Market Characteristics

3. Antimicrobial Susceptibility Testing Market Trends And Strategies

4. Antimicrobial Susceptibility Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Antimicrobial Susceptibility Testing Market Size and Growth

  • 5.1. Global Antimicrobial Susceptibility Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Antimicrobial Susceptibility Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Antimicrobial Susceptibility Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Antimicrobial Susceptibility Testing Market Segmentation

  • 6.1. Global Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Antibacterial Testing
  • Antifungal Testing
  • Antiparasitic Testing
  • Other Types
  • 6.2. Global Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Manual Antimicrobial Susceptibility Testing Products
  • Automated Laboratory Instruments
  • Consumables
  • 6.3. Global Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diagnostics
  • Drug Discovery and Development
  • Epidemiology
  • Other Applications
  • 6.4. Global Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Diagnostic Centers
  • Pharmaceutical And Biotechnology Companies
  • Research And Academic Institutes
  • Clinical Research Organizations (CROs)

7. Antimicrobial Susceptibility Testing Market Regional And Country Analysis

  • 7.1. Global Antimicrobial Susceptibility Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Antimicrobial Susceptibility Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Antimicrobial Susceptibility Testing Market

  • 8.1. Asia-Pacific Antimicrobial Susceptibility Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Antimicrobial Susceptibility Testing Market

  • 9.1. China Antimicrobial Susceptibility Testing Market Overview
  • 9.2. China Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Antimicrobial Susceptibility Testing Market

  • 10.1. India Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Antimicrobial Susceptibility Testing Market

  • 11.1. Japan Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Antimicrobial Susceptibility Testing Market

  • 12.1. Australia Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Antimicrobial Susceptibility Testing Market

  • 13.1. Indonesia Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Antimicrobial Susceptibility Testing Market

  • 14.1. South Korea Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Antimicrobial Susceptibility Testing Market

  • 15.1. Western Europe Antimicrobial Susceptibility Testing Market Overview
  • 15.2. Western Europe Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Antimicrobial Susceptibility Testing Market

  • 16.1. UK Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Antimicrobial Susceptibility Testing Market

  • 17.1. Germany Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Antimicrobial Susceptibility Testing Market

  • 18.5. France Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Antimicrobial Susceptibility Testing Market

  • 19.9. Italy Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Antimicrobial Susceptibility Testing Market

  • 20.13. Spain Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Antimicrobial Susceptibility Testing Market

  • 21.1. Eastern Europe Antimicrobial Susceptibility Testing Market Overview
  • 21.2. Eastern Europe Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Antimicrobial Susceptibility Testing Market

  • 22.1. Russia Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Antimicrobial Susceptibility Testing Market

  • 23.1. North America Antimicrobial Susceptibility Testing Market Overview
  • 23.2. North America Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Antimicrobial Susceptibility Testing Market

  • 24.1. USA Antimicrobial Susceptibility Testing Market Overview
  • 24.2. USA Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Antimicrobial Susceptibility Testing Market

  • 25.1. Canada Antimicrobial Susceptibility Testing Market Overview
  • 25.2. Canada Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Antimicrobial Susceptibility Testing Market

  • 26.1. South America Antimicrobial Susceptibility Testing Market Overview
  • 26.2. South America Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Antimicrobial Susceptibility Testing Market

  • 27.1. Brazil Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Antimicrobial Susceptibility Testing Market

  • 28.1. Middle East Antimicrobial Susceptibility Testing Market Overview
  • 28.2. Middle East Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Antimicrobial Susceptibility Testing Market

  • 29.1. Africa Antimicrobial Susceptibility Testing Market Overview
  • 29.2. Africa Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Antimicrobial Susceptibility Testing Market Competitive Landscape And Company Profiles

  • 30.1. Antimicrobial Susceptibility Testing Market Competitive Landscape
  • 30.2. Antimicrobial Susceptibility Testing Market Company Profiles
    • 30.2.1. BioMerieux SA
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Becton Dickinson and Company
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Danaher Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bio-Rad Laboratories Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Antimicrobial Susceptibility Testing Market Competitive Benchmarking

32. Global Antimicrobial Susceptibility Testing Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Antimicrobial Susceptibility Testing Market

34. Antimicrobial Susceptibility Testing Market Future Outlook and Potential Analysis

  • 34.1 Antimicrobial Susceptibility Testing Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Antimicrobial Susceptibility Testing Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Antimicrobial Susceptibility Testing Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!